MB Research Labs
Experience and Innovation
We are a leader in the development of alternative & in vitro sensitization test methods.
MB Research is been performing regulatory Guinea Pig sensitization studies since the 70s. In 1999, MB Research began development of a Flow Cytometry-based Local Lymph Node Assay(LLNA). Later we expanded our capabilites to include the BrdU-ELISA LLNA. Advancing further, MB Research added the In Vitro Sensitization Assay (IVSA) using 3D Human Epidermis models, the h-CLAT, DPRA and now KeratinoSens.
We have the Experience.
MB Research Laboratories is a GLP contract research laboratory that has been conducting acute, subchronic / chronic toxicology and pharmacology studies since 1972.
- MB Research provides industry-leading general toxicology services for the pharmaceutical, biotechnology, medical device and agrochemical industries and government agencies.
- Routine and non-traditional toxicology studies are performed, custom testing services to meet specific testing needs is available.
- Study Directors and technicians strive to consistently deliver exemplary results to support both Good Laboratory Practices(GLP) and non-GLP studies.
Leading with Innovation.
For over 25 years, MB has been advancing Alternative Toxicology by validating and conducting in vitro and alternative tests.
Want to know more about MB Research?